Invivyd Inc (IVVD)
2.22
+0.14
(+6.73%)
USD |
NASDAQ |
Apr 30, 16:00
2.23
+0.01
(+0.45%)
After-Hours: 20:00
Invivyd Shareholders Equity (Quarterly): 177.47M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 177.47M |
| September 30, 2023 | 246.50M |
| June 30, 2023 | 281.56M |
| March 31, 2023 | 326.75M |
| December 31, 2022 | 355.97M |
| September 30, 2022 | 377.44M |
| Date | Value |
|---|---|
| June 30, 2022 | 414.84M |
| March 31, 2022 | 459.39M |
| December 31, 2021 | 558.02M |
| September 30, 2021 | 633.21M |
| June 30, 2021 | -144.62M |
| March 31, 2021 | -103.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-144.62M
Minimum
Jun 2021
633.21M
Maximum
Sep 2021
298.60M
Average
341.36M
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 544.91M |
| Ardelyx Inc | 166.82M |
| Viking Therapeutics Inc | 933.89M |
| Stoke Therapeutics Inc | 159.56M |
| MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 229.18M |
| Total Liabilities (Quarterly) | 51.71M |